| HOME >> BIOLOGY >> TECHNOLOGY |
Shareholders who have questions about the merger or would like assistance in submitting their proxy or voting their shares of Arrow common stock should contact Morrow & Co., which is assisting Arrow, toll-free at 1-800-662-5200.
About Arrow
Arrow develops, manufactures and markets a broad range of clinically advanced, disposable catheters and related products for critical and cardiac care. The company's products are used primarily by anesthesiologists, critical care specialists, surgeons, emergency and trauma physicians, cardiologists, interventional radiologists and other healthcare providers. Arrow's news releases and other company information can be found on the World Wide Web at http://www.arrowintl.com. Arrow's common stock trades on the NASDAQ Global Select Market(TM) under the symbol ARRO.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements, including the anticipated timing for closing of the transaction. A further description of these risks and uncertainties and other important factors that could cause actual results to differ materially from Teleflex or Arrow's expectations can be found in each company's Annual Report on Form 10-K, as amended and in each company's other filing with the SEC. The expectations and assumptions reflected in such forward looking statements may prove incorrect. Neither Teleflex nor Arrow undertakes to publicly update or revise its forward-looking statements as a result of new information, future events, or otherwise.
Additional Information
In connection with the proposed acquisition of Arrow by Teleflex
Incorporated and Arrow's 2007 Annual Meeting of Shareholders, Arrow filed a
definitive proxy statement
'/>"/>
| SOURCE Arrow International, Inc. Copyright©2007 PR Newswire. All rights reserved |